More than 30 years in the pharmaceutical, biotech and medtech industry including clinical research, health economics, reimbursement, pricing and business development working in both operating company level (Australia, Belgium and USA) and at global level based in the USA. Health economic and reimbursement strategic plans and implementation at both global and local operating company level, including from in-licensing to Phase IV trial design. Strategic planning for global pricing & market access, prospective/retrospective health economic research, primary and secondary pricing research, health economic modeling, project management, proposal/protocol writing, and publication development/management.